Hidemaru Yamaguchi
Stock Analyst at Citi
(1.46)
# 3,445
Out of 4,592 analysts
64
Total ratings
51.2%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4587 PeptiDream Inc. | Maintained: Hold | ¥1,600 → ¥1,100 | ¥947 | +16.13% | 3 | Jul 22, 2026 | |
| TYO: 4592 SanBio Company Limited | Upgraded: Buy | ¥1,800 | ¥919 | +95.87% | 1 | Jul 16, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Sell | ¥1,260 → ¥1,500 | ¥1,248 | +20.19% | 5 | May 25, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥2,500 → ¥2,400 | ¥2,202 | +8.99% | 3 | May 1, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | ¥2,953 | -5.18% | 1 | Apr 3, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | ¥2,555 | -21.71% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Buy | ¥2,600 → ¥2,800 | ¥1,782 | +57.17% | 6 | Feb 9, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥5,800 → ¥4,900 | ¥2,568 | +90.85% | 6 | Feb 5, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Maintained: Hold | ¥600 → ¥670 | ¥479 | +39.87% | 4 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Maintained: Buy | ¥1,100 → ¥1,400 | ¥876 | +59.82% | 5 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,900 → ¥6,200 | ¥4,828 | +28.42% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,800 → ¥3,900 | ¥2,324 | +67.81% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,200 → ¥3,500 | ¥3,593 | -2.59% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,750 | ¥2,384 | -26.59% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥10,400 → ¥10,500 | ¥11,100 | -5.41% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,100 → ¥4,600 | ¥3,400 | +35.29% | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,600 | ¥1,884 | +38.00% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,200 → ¥3,500 | ¥4,005 | -12.61% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,410 | ¥2,883 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥960 | ¥1,100 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | ¥2,151 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥12,000 | ¥6,932 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,100 → ¥2,800 | ¥2,909 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 | ¥1,599 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $32.70 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $25.88 | n/a | 1 | Nov 18, 2009 |
PeptiDream Inc.
Jul 22, 2026
Maintained: Hold
Price Target: ¥1,600 → ¥1,100
Current: ¥947
Upside: +16.13%
SanBio Company Limited
Jul 16, 2026
Upgraded: Buy
Price Target: ¥1,800
Current: ¥919
Upside: +95.87%
Sumitomo Pharma Co., Ltd.
May 25, 2026
Maintained: Sell
Price Target: ¥1,260 → ¥1,500
Current: ¥1,248
Upside: +20.19%
Astellas Pharma Inc.
May 1, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,400
Current: ¥2,202
Upside: +8.99%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: ¥2,953
Upside: -5.18%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: ¥2,555
Upside: -21.71%
M3, Inc.
Feb 9, 2026
Maintained: Buy
Price Target: ¥2,600 → ¥2,800
Current: ¥1,782
Upside: +57.17%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Maintained: Buy
Price Target: ¥5,800 → ¥4,900
Current: ¥2,568
Upside: +90.85%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Maintained: Hold
Price Target: ¥600 → ¥670
Current: ¥479
Upside: +39.87%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Maintained: Buy
Price Target: ¥1,100 → ¥1,400
Current: ¥876
Upside: +59.82%
Sep 12, 2025
Maintained: Buy
Price Target: ¥5,900 → ¥6,200
Current: ¥4,828
Upside: +28.42%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,800 → ¥3,900
Current: ¥2,324
Upside: +67.81%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,200 → ¥3,500
Current: ¥3,593
Upside: -2.59%
Aug 28, 2025
Maintained: Hold
Price Target: ¥1,750
Current: ¥2,384
Upside: -26.59%
Aug 27, 2025
Maintained: Buy
Price Target: ¥10,400 → ¥10,500
Current: ¥11,100
Upside: -5.41%
Aug 26, 2025
Maintained: Buy
Price Target: ¥5,100 → ¥4,600
Current: ¥3,400
Upside: +35.29%
Aug 22, 2025
Maintained: Buy
Price Target: ¥2,600
Current: ¥1,884
Upside: +38.00%
Aug 22, 2025
Maintained: Buy
Price Target: ¥4,200 → ¥3,500
Current: ¥4,005
Upside: -12.61%
Jun 26, 2025
Maintained: Hold
Price Target: ¥2,410
Current: ¥2,883
Upside: n/a
Jun 26, 2025
Maintained: Hold
Price Target: ¥960
Current: ¥1,100
Upside: n/a
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: ¥2,151
Upside: n/a
May 27, 2025
Maintained: Buy
Price Target: ¥12,000
Current: ¥6,932
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ¥3,100 → ¥2,800
Current: ¥2,909
Upside: n/a
Nov 26, 2024
Maintained: Hold
Price Target: ¥3,300
Current: ¥1,599
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $32.70
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $25.88
Upside: n/a